The threat of explosive device attacks is an everyday reality in Isreal. Dr. Mauricio Lynn, associate professor of surgery at the University of Miami Miller School of Medicine and director of the Trauma Resuscitation Unit at the Ryder Trauma Center at Jackson Memorial Hospital in Miami, served in the Israeli Defenses Forces for 18 years. He talks with host Dr. Shira Johnson about our preparedness for an explosive device attack on US soil. What have we learned from the experiences of Israelis and others?
Preparedness for an Explosive Devices Attack in the US
Restart
Resume
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Recommended
Details
Presenters
Overview
The threat of explosive device attacks is an everyday reality in Isreal. Dr. Mauricio Lynn, associate professor of surgery at the University of Miami Miller School of Medicine and director of the Trauma Resuscitation Unit at the Ryder Trauma Center at Jackson Memorial Hospital in Miami, served in the Israeli Defenses Forces for 18 years. He talks with host Dr. Shira Johnson about our preparedness for an explosive device attack on US soil. What have we learned from the experiences of Israelis and others?
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
CME/CE
Evolving Our View of the Coagulation Cascade and Stroke Management
0.25 credits
<p><span data-contrast="auto" xml:lang="EN-US">Evolving Our View of the Coagulation Cascade and Stroke Management</span><span data-ccp-props='{"201341983":0,"335559739":0,"335559740":240}'> </span></p>
MinuteCE®
I'm Getting the Hang of This! I Have Two Patients: One At 'Indeterminate Risk' and One At 'High Risk' for Clinically Significant Fibrosis
1.00 credits
<p>I'm Getting the Hang of This! I Have Two Patients: One At 'Indeterminate Risk' and One At 'High Risk' for Clinically Significant Fibrosis</p>
MinuteCE®
M3: Managing the Cardiometabolic Risk in MASH
1.00 credits
<p><span data-contrast="auto" xml:lang="EN-US">M3: Managing the Cardiometabolic Risk in MASH</span><span data-ccp-props='{"201341983":0,"335559739":160,"335559740":259}'> </span></p>
MinuteCE®
Level Up Your Skills: Tailoring Management of HF
0.75 credits
<p>Level Up Your Skills: Tailoring Management of HF</p>
MinuteCE®
Clinical Conundrums in ARIA: Communicating ARIA Risk with Patients Considering Anti-Aβ Therapy
1.25 credits
<p>Clinical Conundrums in ARIA: Communicating ARIA Risk with Patients Considering Anti-Aβ Therapy</p>
NeuroFrontiers
Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids
<p>Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids</p>
MinuteCE®
Understanding hypertrophic cardiomyopathy and recent guidelines
0.52 credits
<p><span data-contrast="none" style="list-style-type: disc;" xml:lang="EN-US">Understanding hypertrophic cardiomyopathy and recent guidelines</span></p>
MinuteCE®
Echocardiographic workup for HCM – making the diagnosis and evaluation of cardiac function Keywords (Image): Faculty screenshot
0.52 credits
<div>
<p><span data-contrast="none" xml:lang="EN-US">Echocardiographic workup for HCM – making the diagnosis and evaluation of cardiac function</span></p>
</div>
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?